Showing 1 - 14 results of 14 for search 'Elisabetta A. Renzoni', query time: 0.08s
Refine Results
-
1
-
2
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial by Peter Saunders, Vicky Tsipouri, Gregory J. Keir, Deborah Ashby, Marcus D. Flather, Helen Parfrey, Daphne Babalis, Elisabetta A. Renzoni, Christopher P. Denton, Athol U. Wells, Toby M. Maher
Published 2017-06-01
Article -
3
Research highlights from the 2018 ERS International Congress: interstitial lung diseases by Tiago M. Alfaro, Catharina C. Moor, Veronica Alfieri, Florence Jeny, Michael Kreuter, Marlies S. Wijsenbeek, Elisabetta A. Renzoni, Elena Bargagli, Hilario Nunes, Paolo Spagnolo, Francesco Bonella, Maria Molina-Molina, Katerina Antoniou, Venerino Poletti
Published 2019-02-01
Article -
4
Overnight desaturation in interstitial lung diseases: links to pulmonary vasculopathy and mortality by George A. Margaritopoulos, Athanasia Proklou, Athina Trachalaki, Diana Badenes Bonet, Maria Kokosi, Vasilis Kouranos, Felix Chua, Peter George, Elisabetta A. Renzoni, Anand Devaraj, Sujal Desai, Andrew G. Nicholson, Katerina M. Antoniou, Athol U. Wells
Published 2024-02-01
Article -
5
ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly by Clairelyne Dupin, Vânia Fernandes, Fernanda Hernandez-Gonzalez, Sebastiano Emanuele Torrisi, Tiago M. Alfaro, Michael Kreuter, Marlies S. Wijsenbeek, Elisabetta A. Renzoni, Elena Bargagli, Hilario Nunes, Paolo Spagnolo, Francesco Bonella, Maria Molina-Molina, Katerina Antoniou, Venerino Poletti
Published 2020-10-01
Article -
6
Muscle stimulation in advanced idiopathic pulmonary fibrosis: a randomised placebo-controlled feasibility study by William D-C Man, Matthew Maddocks, Toby M Maher, Athol U Wells, Elisabetta A Renzoni, Suhani Patel, Felix Chua, Philip L Molyneaux, Peter M George, Ruth E Barker, Claire M Nolan, Oliver Polgar, Vasilis Kouranos
Published 2021-06-01
Article -
7
First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative by Nynke A Kampstra, Jan C Grutters, Frouke T van Beek, Daniel A Culver, Robert P Baughman, Elisabetta A Renzoni, Wim Wuyts, Vaslis Kouranos, Marlies S Wijsenbeek, Douwe H Biesma, Philip J van der Wees, Paul B van der Nat
Published 2019-10-01
Article -
8
Ambulatory oxygen in fibrotic lung disease (AmbOx): study protocol for a randomised controlled trial by Dina Visca, Vicky Tsipouri, Letizia Mori, Ashi Firouzi, Sharon Fleming, Morag Farquhar, Elizabeth Leung, Toby M. Maher, Paul Cullinan, Nick Hopkinson, Athol U. Wells, Winston Banya, Jennifer A. Whitty, Huzaifa Adamali, Lisa G. Spencer, Piersante Sestini, Elisabetta A. Renzoni
Published 2017-04-01
Article -
9
ERS International Congress 2021: highlights from the Interstitial Lung Diseases Assembly by Sabina A. Guler, Sara Cuevas-Ocaña, Mouhamad Nasser, Wim A. Wuyts, Marlies S. Wijsenbeek, Antoine Froidure, Elena Bargagli, Elisabetta A. Renzoni, Marcel Veltkamp, Paolo Spagnolo, Hilario Nunes, Cormac McCarthy, Maria Molina-Molina, Francesco Bonella, Venerino Poletti, Michael Kreuter, Katerina M. Antoniou, Catharina C. Moor
Published 2022-05-01
Article -
10
Results of the standard set for pulmonary sarcoidosis: feasibility and multicentre outcomes by Nynke A. Kampstra, Paul B. van der Nat, Lea M. Dijksman, Frouke T. van Beek, Daniel A. Culver, Robert P. Baughman, Elisabetta A. Renzoni, Wim Wuyts, Vasilis Kouranos, Pieter Zanen, Marlies S. Wijsenbeek, Marinus J.C. Eijkemans, Douwe H. Biesma, Philip J. van der Wees, Jan C. Grutters
Published 2019-10-01
Article -
11
Rituximab compared to intravenous cyclophosphamide in adults with connective tissue disease-associated interstitial lung disease: the RECITAL RCT by Toby M Maher, Veronica A Tudor, Peter Saunders, Fernando Zanghelini, Carlota Grossi Sampedro, Georgios Xydopoulos, Michael Gibbons, Sophie V Fletcher, Christopher P Denton, Maria Kokosi, Rachel K Hoyles, Helen Parfrey, Elisabetta A Renzoni, Athol U Wells, Deborah Ashby, Richard J Fordham, Matyas Szigeti, Philip L Molyneaux
Published 2024-02-01
Article -
12
Nintedanib for non-IPF progressive pulmonary fibrosis: 12-month outcome data from a real-world multicentre observational study by Lavanya Raman, Iain Stewart, Shaney L. Barratt, Felix Chua, Nazia Chaudhuri, Anjali Crawshaw, Michael Gibbons, Charlotte Hogben, Rachel Hoyles, Vasilis Kouranos, Jennifer Martinovic, Sarah Mulholland, Katherine J. Myall, Marium Naqvi, Elisabetta A. Renzoni, Peter Saunders, Matthew Steward, Dharmic Suresh, Muhunthan Thillai, Athol U. Wells, Alex West, Jane A. Mitchell, Peter M. George
Published 2023-03-01
Article -
13
Multi-center evaluation of baseline neutrophil-to-lymphocyte (NLR) ratio as an independent predictor of mortality and clinical risk stratifier in idiopathic pulmonary fibrosisResea... by Theresia A. Mikolasch, Peter M. George, Jagdeep Sahota, Thomas Nancarrow, Shaney L. Barratt, Felix A. Woodhead, Vasilis Kouranos, Victoria S.A. Cope, Andrew W. Creamer, Silan Fidan, Balaji Ganeshan, Luke Hoy, John A. Mackintosh, Robert Shortman, Anna Duckworth, Janet Fallon, Helen Garthwaite, Melissa Heightman, Huzaifa I. Adamali, Sarah Lines, Thida Win, Rebecca Wollerton, Elisabetta A. Renzoni, Matthew Steward, Athol U. Wells, Michael Gibbons, Ashley M. Groves, Bibek Gooptu, Chris J. Scotton, Joanna C. Porter
Published 2023-01-01
Article -
14
Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndrome by Sara Remuzgo-Martínez, Belén Atienza-Mateo, J. Gonzalo Ocejo-Vinyals, Fernanda Genre, Verónica Pulito-Cueto, Víctor M. Mora-Cuesta, David Iturbe-Fernández, Leticia Lera-Gómez, Raquel Pérez-Fernández, Diana Prieto-Peña, Juan Irure, Fredeswinda Romero-Bueno, Olga Sanchez-Pernaute, Rodrigo Alonso-Moralejo, Laura Nuño, Gema Bonilla, Esther F. Vicente-Rabaneda, Ignacio Grafia, Sergio Prieto-González, Javier Narvaez, Ernesto Trallero-Araguas, Albert Selva-O’Callaghan, Spanish Biomarkers of Antisynthetase Syndrome Consortium, Spanish Biomarkers of Interstitial Lung Disease Consortium, Oreste Gualillo, Lorenzo Cavagna, José M. Cifrián, Elisabetta A. Renzoni, Santos Castañeda, Raquel López-Mejías, Miguel A. González-Gay
Published 2021-11-01
Article